Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)
Bristol-Myers Squibb(BMY) Seeking Alpha·2025-03-12 21:46Company Overview - Bristol-Myers Squibb (BMS) has a strong presence in the healthcare sector, particularly in immunology, cardiology, and neuroscience, with a focus on innovative drug development [3]. Leadership and Experience - Roland Chen, Head of Development for Immunology, Cardiology, and Neuroscience at BMS, has been with the company for approximately 25 years, contributing significantly to development, safety, and outcomes research [3]. Pipeline and Future Prospects - BMS is currently experiencing a pivotal moment with a rich and innovative pipeline of assets, including several key late-stage readouts expected in the coming years [4].